These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22874415)

  • 41. Insights Into the Differential Desensitization of
    Papke RL; Stokes C
    Mol Pharmacol; 2023 Feb; 103(2):63-76. PubMed ID: 36414373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
    Xiao Y; Abdrakhmanova GR; Baydyuk M; Hernandez S; Kellar KJ
    Acta Pharmacol Sin; 2009 Jun; 30(6):842-50. PubMed ID: 19448648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists.
    Briggs CA; McKenna DG
    Neuropharmacology; 1998 Sep; 37(9):1095-102. PubMed ID: 9833639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Side Groups Convert the α7 Nicotinic Receptor Agonist Ether Quinuclidine into a Type I Positive Allosteric Modulator.
    Viscarra F; Chrestia JF; Sanchez Y; Pérez EG; Biggin PC; Bouzat C; Bermudez I; López JJ
    ACS Chem Neurosci; 2023 Aug; 14(16):2876-2887. PubMed ID: 37535446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
    Faghih R; Gfesser GA; Gopalakrishnan M
    Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stable desensitization of α
    Pismataro MC; Horenstein NA; Stokes C; Dallanoce C; Thakur GA; Papke RL
    Eur J Pharmacol; 2021 Aug; 905():174179. PubMed ID: 34004208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice.
    Abbas M; Alzarea S; Papke RL; Rahman S
    Pharmacol Rep; 2019 Dec; 71(6):1168-1176. PubMed ID: 31655281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons.
    Fayuk D; Yakel JL
    Mol Pharmacol; 2004 Sep; 66(3):658-66. PubMed ID: 15322258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
    Akk G; Steinbach JH
    J Neurosci; 2005 Feb; 25(8):1992-2001. PubMed ID: 15728839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of allosteric modulators and transmembrane mutations on desensitisation and activation of α7 nicotinic acetylcholine receptors.
    Chatzidaki A; D'Oyley JM; Gill-Thind JK; Sheppard TD; Millar NS
    Neuropharmacology; 2015 Oct; 97():75-85. PubMed ID: 25998276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice.
    Nakauchi S; Sumikawa K
    Eur J Neurosci; 2012 May; 35(9):1381-95. PubMed ID: 22462479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia.
    Hajós M; Rogers BN
    Curr Pharm Des; 2010; 16(5):538-54. PubMed ID: 19909231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photo-induced covalent attachment of agonists as a tool to study allosteric mechanisms of nicotinic acetylcholine receptors.
    Mourot A; Kotzyba-Hibert F; Goeldner M; Bamberg E
    J Mol Neurosci; 2006; 30(1-2):3-4. PubMed ID: 17192602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.
    Peng C; Kimbrell MR; Tian C; Pack TF; Crooks PA; Fifer EK; Papke RL
    Mol Pharmacol; 2013 Sep; 84(3):459-75. PubMed ID: 23839567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptors.
    Placzek AN; Grassi F; Papke T; Meyer EM; Papke RL
    Mol Pharmacol; 2004 Jul; 66(1):169-77. PubMed ID: 15213309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid upregulation of alpha7 nicotinic acetylcholine receptors by tyrosine dephosphorylation.
    Cho CH; Song W; Leitzell K; Teo E; Meleth AD; Quick MW; Lester RA
    J Neurosci; 2005 Apr; 25(14):3712-23. PubMed ID: 15814802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type.
    Lewis TM; Harkness PC; Sivilotti LG; Colquhoun D; Millar NS
    J Physiol; 1997 Dec; 505 ( Pt 2)(Pt 2):299-306. PubMed ID: 9423173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α7-Containing and non-α7-containing nicotinic receptors respond differently to spillover of acetylcholine.
    Stanchev D; Sargent PB
    J Neurosci; 2011 Oct; 31(42):14920-30. PubMed ID: 22016525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.